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In recent years much evidence has accumulated which demonstrates that an animal's 
immune system has the capacity to recognize its own antibody idiotypes. These findings 
suggest  a  potential  role  for  self-idiotypic recognition  in  controlling  B-cell  antibody 
responses (1-3). In this report we describe experiments designed to test the postulate that 
subsequent to primary immunization and concomitant with an initial antibody response 
to an  antigen  an  animal  develops the ability to specifically regulate the  synthesis of 
antibodies specific for the stimulating antigen. This regulation may be envisaged as a 
means by which the immune system specifically limits the expression of antigen-specific 
B cells once an adequate humoral immune response has ensued. 
The kinetics of appearance of antigen-specific antibody in the  serum of immunized 
animals  after  primary immunization has  been  well  documented  (4-7).  Although the 
antibody  synthesized  is  specific  for  the  stimulating  antigen,  for  most  antigens  the 
antibody population is extremely heterogeneous. This heterogeneity is a reflection of the 
heterogeneity of the B-cell repertoire in that each B cell synthesizes antibody of a single 
specificity  (4,  8-12).  On  this  basis  one  would  predict  that,  if an  immunoregulatory 
mechanism does indeed develop after a  primary antibody response,  it would be highly 
specific for the B cells synthesizing the particular antibodies induced during the primary 
immune response. Thus, antibody responses to unrelated antigens would be unaffected in 
the immunized animal.  Considering the heterogeneity of the initial antibody response, 
this regulation would presumably involve the recognition of individual antibody-produc- 
ing B cells. 
A further consideration which must be made is that secondary antibody responses, by 
definition, occur in previously immunized animals. This would imply that the population 
of secondary B cells which is generated as a consequence of primary immunization (4, 13, 
14) is not susceptible to immunoregulatory mechanisms elicited in an individual during a 
primary antibody response. If a regulatory mechanism does involve the specific recogni- 
tion of B cells synthesizing antibody elicited during primary immunization one might 
predict that secondary B cells would be susceptible to this regulation as evidence exists 
which suggest that secondary B cells may, in part, express the same antibody idiotypes as 
the B cells from nonimmtme animals (15, 16). However, secondary B cells differ from 
primary B cells in many characteristics of their stimulation and tolerance induction (4, 
14, 16) and these differences may explain their ability to be stimulated in an environment 
which suppresses primary B-cell  antibody synthesis. 
We  have  employed  the  in  vitro  splenic  focus  fragment  culture  system  to 
investigate whether a  specific immunoregulation develops after immunization 
(4,  17).  The results indicated that only 25-35% of dinitrophenyl (DNP)l-specific 
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primary B cells which responded to DNP-hemocyanin (Hy) in recipients immu- 
nized with Hy alone could be stimulated by DNP-Hy in recipients previously 
immunized with DNP-Hy. This inhibition appeared to affect exclusively DNP- 
specific primary B cells expressing the recipients allotype-linked locus immuno- 
globulin genes and did not affect secondary DNP-specific B-cell responses. 
Materials and Methods 
Proteins  and Haptenated  Proteins.  Limulus polyphemus Hy was purchased from Worthington 
Biochemical Corp., Freehold, N. J. The preparation of 2,4-dinitrophenylated-hemocyanin (DNPI0- 
Hy, 10 mol of DNP per 100,000 g of Hy) and 2, 4, 6-trinitrophenylated-hemocyanin (TNPlo-Hy) have 
been previously described (4). Fluoresceinated hemocyanin (FL~o-Hy) was prepared as previously 
described  (18). The preparation  of 4-hydroxy-3-nitrophenylated-Hy (NPlo-Hy)  and 4-hydroxy-3- 
iodo-5-nitrophenylated-bovine serum albumin  (NIPlo-BSA)  has  been  described elsewhere  (19). 
DNP~o-BSA, TNP~o-BSA, and FL~o-BSA were prepared as described elsewhere (4,  18). 
Animals.  6- to 8-wk-old  BALB/cAnN mice were acquired through the Institute for Cancer 
Research, Philadelphia,  Pa. BI0.D2 mice were obtained from The Jackson Laboratory, Bar Harbor, 
Maine. CB20 mice were supplied by Dr. Michael Potter, National Cancer Institute,  National 
Institutes  of Health, Bethesda, Md., through the Litton Bionetics,  Kensington, Md. breeding 
colony operating under National Cancer Institute  contract  no. NOI-CB-92142. 
Immunizations.  BALB/c and B10.D2 mice used as carrier-primed recipients  of  cell  transfers 
received an intraperitoneal  injection  of  0.1 mg Hy in complete Freund's adjuvant (CFA) 5-8 wk 
before use.  Animals used as hapten-Hy-primed recipients  were immunized in one of two ways. 
Mice received  either  a single  intraperitoneal  injection  of  a mixture of  0.1  mg Hy and 0.1  mg hapten- 
Hy in CFA 5-8 wk before use or 0.1 mg Hy in CFA in a single  intraperitoneal  injection  5-8 wk 
before  use followed  by a separate injection  of  0.1 mg hapten-Hy in CFA 2 wk before  use. Groups of 
animals immunized in these two ways were used interchangeably in the studies  presented since 
results  of  initial  studies demonstrated no difference  in the immunoregulatory capacity of mice 
immunized by either  regimen. Animals used  as  donors of  secondary B cells  were injected  with 0.1 
mg DNPIo-Hy in CFA intraperitoneally  5-8 wk before use. 
Cell Transfers  and Fragment Cultures.  The methodology for obtaining monoclonal antibody 
responses in  splenic  fragment cultures  has been previously described (4,  17).  Briefly,  spleens from 
immunized or unimmunized mice were prepared in a single cell  suspension by perfusion of  the 
spleen with Dulbecco's modified Eagles medium. Appropriate numbers of  cells  from these suspen- 
sions  were injected  intravenously into  carrier-primed or hapten carrier-primed recipients  which 
had  been irradiated  at  1,300  rad  6 h earlier.  Fragment cultures  of  recipient  spleens  were prepared 16 
h after  cell  transfer  and fragments were individually  stimulated with the appropriate hapten-Hy 
conjugate at a hapten concentration of 10  -6 M.  Anti-DNP,  anti-TNP,  anti-FL, and anti-NP 
antibodies were detected in culture fluids  collected  9 and 12 days after  in vitro  stimulation by 
using a modification (16)  of a solid  phase radioimmunoaseay  described by Catt and Tregar (1, 
20).  DNPIo-BSA, TNPI0-BSA, FL~0-BSA, or NIP~o-BSA were used to coat wells  of  disposable  poly- 
vinyl chloride microtiter plates, Cooke Laboratory  Products Div., Dynatech Laboratories Inc., 
Alexandria, Va. Antibodies to DNP, TNP, and FL in  culture  fluids  were detected in  this  assay in 
microtiter  plates coated with the homologous hapten-BSA conjugates. Anti-NP antibodies were 
detected  by assaying culture  fluids  in microtiter  plates  coated with NIP~o-BSA. Culture fluids  were 
quantitatively  assayed for  anti-hapten antibody by using 12SI-labeled  anti-mouse Fab, IgG~  (~,~),  or 
IgM (/~)  antibodies  as detecting  reagents (4, 21). 
Results 
The  Effect  of  Hapten-Carrier  Immunization  on  Primary  B-CeU  Re- 
sponses.  Previous reports have indicated that antibody specific for DNP can be 
detected in the serum of mice approximately 3-5 days aider immunization with 
DNP-Hy  (6,  7).  The  anti-DNP antibody  concentration in the serum  then  in- 
creases dramatically from the 2nd to 3rd wk postimmunization and reaches maxi- 
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TABLE  I 
Primary Anti-DNP-Specific Donor B-Cell Responses  in Hy and DNP-Hy Immunized 
Recipient Mice at Various Times after Recipient Immunization 
No. of weeks postim- 
munization with DNP- 
Hy before cell transfer* 
Total no. donor cells 
analyzed x  10-65 
No. positive foci per 
10  s spleen cells trans- 
ferred§ 
Response detected in 
recipients immunized 
with Hy alonelt 
% 
Unimmunized  48  1.83  - 
2  32  0.44  24.0 
4  16  0.25  13.7 
8  32  0.75  41.0 
18  16  0.50  27.3 
22  8  0.50  27.3 
* All donor and recipient mice were of  the BALB/c strain. All donor mice were immunized with 0.1 
mg Hy in CFA 8-22 wk before cell transfer. 
$ Each recipient received 4  ×  10  ~ donor BALB/c spleen cells. 
§ All cultures were stimulated in vitro with DNP-Hy at a  DNP concentration of 10  -s M. Positive 
foci were detected by assaying culture fluids for anti-DNP antibody. 
II This number represents the percent of positive foci detected in Hy-primed recipient mice which 
were detected in DNP-Hy +  Hy immunized recipient mice. 
anti-DNP  antibody decreases gradually  thereafter  and  anti-DNP  antibody  is 
barely detectable 8 wk after immunization  (6). The experiments to be presented 
in this report were initiated to determine whether during the course of such a 
primary immune response there is a  progressive change in the environment of 
the immune host which specifically affects the responses of primary B cells. 
The in vitro fragment culture system was employed to compare primary donor 
B-cell responses to DNP-Hy in DNP-Hy immunized recipients at various times 
after  immunization  to those of the  same  donor  cell population  transferred  to 
recipients  immunized with  Hy alone.  In the splenic fragment culture system, 
primary B-cell responses to hapten-carrier conjugates are absolutely dependent 
on the carrier-priming  of the recipient mouse (4). Therefore, all DNP-Hy immu- 
nized  mice  were  also  immunized  with  nonhaptenated  Hy  to  insure  carrier 
recognition for other hapten-Hy conjugates in the recipients spleens. The results 
shown  in  Table  I  indicate  that  the  number  of DNP-specific primary  B  cells 
responding in fragment cultures derived from recipients immunized with DNP- 
Hy was significantly decreased as compared to the number of DNP-specific B 
cells responding  in spleen fragments  of recipients  immunized  with  Hy alone. 
This decrease was observed as early as 2 wk after immunization  when serum 
anti-DNP antibody concentrations in recipients were at a maximum, to as late 
as 8-22 wk after immunization  when anti-DNP antibody was barely detectable 
in the serum of recipient mice. 
A summary of the results obtained by using a variety of haptens coupled to Hy 
for both in vivo immunization  and in vitro stimulation is presented in Table II. 
As shown,  only 29.5%  of all DNP-specific primary B  cells produced detectable 
DNP-specific antibody in DNP-Hy immunized BALB/c mice as compared to the 
same donor cells in Hy immunized recipient mice. Similar results were obtained 
by using hapten-Hy conjugates other than DNP-Hy (such as TNP-Hy and FL- 
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TABLE  II 
Primary Anti-Hapten-Specific  Donor B-Cell Responses  in Recipient Mice Immunized 
with Either Carrier or Hapten Carrier 
Recipient immu-  In vitro stimulat-  No. positive foci  Response in 
nization*  ing hapten-Hy  No. donor cells  per l0  s spleen  Hy-primed  analyzed × 10  -e  conjugate*  cells transferred§  recipients [] 
% 
Hy  DNP - Hy  48  ,1.83  - 
DNP -Hy +Hy  DNP -Hy  52  0.54  29.5 
Hy  TNP -Hy  20  1.85  - 
TNP -Hy +Hy  TNP -Hy  20  0.55  29.7 
Hy  FL -Hy  16  1.40  - 
FL-Hy +Hy  FL -Hy  24  0.50  35.7 
* Donor and recipient mice were of the BALB/c strain.  Recipient  mice received  4 x  10  e donor 
spleen cells. Recipients were primed as described in Materials and Methods section. 
$ All in vitro cultures stimulated with hapten-Hy conjugates  at 10  -6 M hapten. 
§ Positive foci were detected  by assaying culture  fluids  for antibody specific for the  in  vitro 
stimulating hapten. 
I] This number represents the percent of positive foci detected in Hy immunized recipient mice 
which were detected in hapten-Hy + Hy immunized recipients. 
The responses of primary B  cells to other haptens coupled to Hy in DNP-Hy 
and TNP-Hy immunized recipients were tested and the results are presented in 
Tab.le  III.  As  shown,  the  frequencies  of anti-FL  primary  B-cell  responses  in 
DNP-Hy immunized recipients  and anti-NP primary B-cell responses in TNP- 
Hy immunized recipients were,  if anything,  slightly enhanced as compared to 
responses of the same donor cell population in recipients primed with Hy alone. 
Preliminary  experiments  not  presented  have  indicated  that  the  frequency  of 
DNP-specific primary B-cell responses may be nearly equivalent in TNP-Hy and 
Hy immunized recipient  mice.  These results  indicate that the  decrease  in the 
frequency  of DNP-specific  B-cell  responses  in  DNP-Hy immunized  recipients 
can  not  be  attributed  to  the  lack  of adequate  Hy-specific  T-cell  help  since 
responses to heterologous haptens coupled to Hy were not diminished in these 
recipients.  Thus,  the  inability  of primary  B  cells  to  respond  to  hapten-Hy 
conjugates  in  recipient  mice  which  have  been  previously immunized  to  that 
hapten coupled to Hy appear to be the result of a  specific, irradiation resistant 
regulation of primary B-cell responses present in the immunized recipient. 
The  Target  of the  Immunoregulation.  Experiments  were  carried  out  to 
identify the  gene  products  of primary B  cells  which  served  as  targets  of this 
suppressive phenomenon. Appropriate mouse strain combinations were selected 
so that donor and recipient strains shared genes in the major histocompatibility 
complex of the  mouse  (H-2),  thus  maximizing  primary  B-cell responsiveness 
(22-24)  but  differed,  to  various  degrees,  in  genes  outside  that  complex.  The 
results of these experiments, summarized in Table IV, demonstrate that if donor 
and recipient strains shared only genes within the H-2 complex and differed in 
all genes outside that complex, as in the BALB/c and B10.D2 combination, the 
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TABLZ  III 
The Hapten-Specific  Responses of Donor Cells in Recipient Mice Immunized with 
Carrier or Hapten Carrier Complexes 
No. positive loci  Response in Hy- 
Recipient  In vitro  antigens  No. cells  ana-  per 108 cells  primed 
priming*  lyzed x 10  -~  transferred§  recipientsH 
% 
Hy  DNP  -Hy  48  1.80  - 
DNP  -Hy  +Hy  DNP -Hy  54  0.54  29.3 
Hy  FL -Hy  32  1.40  - 
DNP  -Hy  +  Hy  FL -Hy  32  1.50  107.1 
Hy  NP - Hy  60  0.25  - 
TNP  -Hy  +Hy  NP -Hy  60  0.30  125.0 
* All donor and recipient mice are of  the BALB/c strain. 4 x 106 donor cells  were transferred to 
each recipient stimulated with FL-Hy or DNP-Hy  in vitro  and 10 x 10  e  cells  were transferred to 
each recipient stimulated with NP-Hy  in vitro. 
$ All cultures were stimulated in vitro  with hapten Hy conjugates at 10  -s M  hapten. 
§ Positive  foci were detected by assaying culture  fluids for antibody  specific for the in vitro 
stimulating hapten. 
II  This number represents the percent of positive loci  detected in Hy immunized  recipient mice 
which were detected in hapten-Hy  + Hy immunized recipients. 
TABLE  IV 
The Identification of the Genetic Region Associated with the Suppression of  Primary B- 
Cell Responses 
No.  anti- 
No.  cells  DNP posi-  Response in 
Recipi-  Recipient prim-  analyzed  tive foci per  Hy-primed  Donor*  Donor al-  Recipient  ent allo- 
lotype$  types  ing  ×  10 -6  10  e cells  recipients 
transferred§ 
% 
BALB/c  a ~  BALB/c  a ~  Hy  48  1.83  - 
BALB/c  a ~  BALB/c  a I  DNP  -Hy  +Hy  52  0.54  29.5 
B10.D2  a 2  BALB/c  a I  Hy  32  1.88  - 
B10.D2  a s  BALB/c  a ~  DNP  -Hy  +Hy  32  2.00  106.4 
CB20  a  2  BALB/c  a  I  Hy  16  1.87  - 
CB20  a  2  BALB/c  a  I  DNP  -Hy  +Hy  16  2.00  106.9 
* 4  x  106 donor cells were transferred to each recipient. All donor and recipient strains are of the 
H-2  ~ haplotype (26). 
$ Allotype according to Leiberman et al.  (25). 
§ All cultures were stimulated in vitro with DNP-Hy at 10 -6 M DNP. Positive foci were detected by 
assaying culture fluids for DNP-specific antibody. 
DNP-Hy  immunized  recipients.  Further,  if donor  and  recipient  strains  were 
identical  with  the  exception  of genes  which  code  for  immunoglobulin  heavy 
chains,  as  in  the  BALB/c  and  CB20  strain  combination  (25),  the  frequency  of 
donor  anti-DNP  specific  B-cell  responses  in  DNP-Hy-primed  recipients  was 
equivalent  to  the  frequency  in  Hy-primed  recipients.  Although  not  shown  in 514  ANTIBODY-SPECIFIC  IMMUNOREGULATION 
Table  IV,  similar  results  were obtained  by using  B10.D2  and  CB20 mice  as 
recipients of BALB/c donor cells. Thus, it appears that, after immunization with 
a hapten-carrier  complex, a regulatory mechanism is established which affects 
only  hapten-specific  B  cells  which  respond  to  the  hapten  with  heavy chains 
common to the recipient strain.  It should be noted that the unimpaired respon- 
siveness of B10.D2 and CB20 DNP-specific primary B cells in DNP-Hy immu- 
nized BALB/c recipients implies that the regulation is unlikely the result of a 
nonspecific suppression mediated by recipient antibody specific for DNP-Hy. 
The Effect  of Recipient Hapten-Carrier Immunization  on  Secondary  B-CeU 
Responses.  As a consequence of primary immunization with T-dependent anti- 
gens,  animals  appear  better  equipped  to  respond  to  the  same  antigen  upon 
reimmunization.  After secondary immunization,  serum antibody concentrations 
reach higher levels earlier and persist in the serum longer than after primary 
immunization  (4-7).  This change in the kinetics of the humoral  response has 
been related in part to the generation of a population of secondary B cells (4, 13, 
14). Since it is clear that these secondary B cells are able to respond in vivo to 
DNP-Hy in the milieu of the DNP-Hy immunized animal,  it was of interest to 
determine if hapten-specific secondary B cells would be fully responsive in the 
fragment  cultures  derived from hapten-carrier-primed  recipients.  The  results 
shown in Table V demonstrate that spleen cells from BALB/c mice previously 
immunized  to DNP-Hy responded in approximately the same frequency when 
transferred to Hy-primed or DNP-Hy-primed recipients.  This was also true for 
spleen cells from FL-Hy immunized  BALB/c mice transferred  to either  Hy or 
FL-Hy immunized BALB/c recipients. It thus appears that secondary B cells are 
not  susceptible to  the  regulatory  mechanism  established  after  a  primary  re- 
sponse to T-dependent antigens which affects primary B-cell responses. 
Discussion 
Based on the assumption that the induction and progression of the humoral 
immune response is a  specifically regulated biological process, several investi- 
gators have  suggested theories  of immunoregulation  and tested these experi- 
mentally.  Many  models  of immunoregulation  propose  a  regulatory  role  for 
serum antibody specific for determinants of the stimulating antigen and antigen 
antibody complexes in both the stimulation and inhibition of B-cell responses to 
these particular determinants  (27,  28).  Generally,  in these models, the level of 
serum  antibody  modulates  the  immune  response  by  a  feedback  mechanism 
which is dependent on the concentration of antigen  antibody complexes or the 
availability  of unbound  antigenic  determinants.  More  recently,  it  has  been 
proposed that  regulation  of the humoral  immune  response  may be mediated 
directly through  the  specific recognition  of the  idiotypic determinants  of the 
surface receptors of the antigen-specific responding B cells (1-3, 15, 29, 30). The 
rationale for this model is based on the fact that most antigens elicit antibodies 
bearing  many  different  idiotypic specificities  and  it is thought  that  selective 
regulation  of these idiotypes might  be mediated better through  anti-idiotypic 
recognition than through antigen. 
The  experiments  presented  here  were  carried  out  to  determine  whether 
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TABLE V 
Secondary Anti-Hapten-Specific  B-Cell Responses  in Recipients Immunized with 
Carrier or Hapten-Carrier 
No. cells  No. positive  Response in 
foci per 10  e  Donor immu-  Recipient immu-  In vitro  analyzed x  Hy-primed re- 
cells trans-  nization*  nization  antigen  10_  ~  ferred*  cipients 
% 
DNP - Hy  Hy  DNP -  Hy  16  6.94  - 
DNP -Hy  DNP -Hy  +Hy  DNP  -Hy  16  6.78  97.7 
FL - Hy  Hy  FL - Hy  8  2.62  - 
FL -Hy  FL -Hy  +Hy  FL -Hy  8  2.25  85.9 
* All donor and recipient mice are of the BALB/c strain. 2  x  10  e donor cells were transferred to 
each recipient. 
$ Positive foci detected by assaying culture fluids for antibody specific for the in vitro stimulating 
hapten. 
develop the capacity to specifically regulate the response of primary B cells to 
the immunizing antigen. To this end, BALB/c mice were immunized with either 
Hy alone or DNP-Hy in addition to Hy and used as recipients of donor primary B 
cells in  the  splenic  fragment  culture  system.  By immunizing  recipients  with 
DNP-Hy and  Hy and  comparing  results  obtained in these recipients  to those 
obtained in recipients immunized with Hy alone,  it was possible to assess the 
effect of DNP-Hy immunization  on primary  anti-DNP  responses  in  a  splenic 
environment which provides carrier-specific help (4).  The results demonstrate 
that  for weeks after  immunization  with  DNP-Hy, immunized  mice  were not 
capable of enabling the responses of most transferred  DNP-specific primary B 
cells.  This  nonpermissive environment  for primary anti-DNP B-cell responses 
was specific for the immunizing hapten since FL- and NP-specific primary B-cell 
responses  were  unimpaired  in  DNP-Hy  or  TNP-Hy  immunized  recipients, 
respectively, as compared to Hy-primed recipient mice. By selecting appropriate 
donor recipient strain combinations, it was possible to demonstrate that genes or 
gene products of the immunoglobulin heavy chain locus played an essential role 
in determining  if primary B cells were subject to this suppression. 
Thus, it would appear that during an initial humoral immune response to a T- 
dependent antigen, a regulatory mechanism is induced which specifically limits 
the  stimulation  of hapten-specific  primary  B  cells.  The studies  reported here 
have characterized several aspects of this immunoregulation.  (a) The suppres- 
sion is irradiation resistant.  (b) The suppression is specific for responses to the 
inducing  hapten  and  may  discriminate  between  very  similar  cross-reacting 
haptens.  (c) The regulatory process is evident only in immunized  individuals 
and acts only on primary B cells and specifically those which share genes coding 
for immunoglobulin heavy chains with the immunized recipient mouse. (d) The 
lack  of response  of primary  B  cells  is not due to the  absence  of appropriate 
carrier-specific  T-cell  help  since  other  haptens  on  the  same  carrier  induce 
primary responses.  (e) Maintenance  of the suppression does not appear to be 
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It  is  possible,  however,  that  anti-DNP  antibody,  as  a  serum product  or  as 
receptors of responding DNP-specific B cells, may have been essential for the 
induction of this regulatory phenomenon. 
In  postulating  a  mechanism by which DNP-Hy  immunized recipients are 
capable  of specifically regulating  primary  B-cell  stimulation  two  points  are 
critical:  that  the suppression  be  specific and that  it  pertain  only to  B  cells 
expressing  the  same  immunoglobulin  genes  as  the  recipient.  We  have  not 
demonstrated that  this  regulation is  idiotype specific,  in  that  the  available 
genetic data could indicate that either VH or CH genes may provide targets of 
this  immunoregulation.  However,  knowing  that  the  regulation  is  antibody 
specific, the specificity of the regulation for the response to  the immunizing 
hapten might argue that this is a regulation mediated through specific idiotype 
recognition. 
Much evidence has accumulated which attests to the ability of antibody to 
specific immunoglobulin idiotypes or allotypes to suppress or stimulate B cells 
and thus regulate responses of B cells bearing the particular idiotype or allotype 
(29, 31,  32). These  findings  have  led Rodkey,  KShler,  and Jerne to  propose 
regulatory  networks  of antibody  idiotypes  and  anti-idiotypes  interacting  to 
modulate or regulate immune responses (1-3). However, the immunoregulatory 
capacity of anti-idiotypic reactivity has generally been observed experimentally 
in vivo only after passive transfer of anti-idiotypic antibody to animals which 
respond to a particular antigen with antibody of that idiotype (29, 33). Attempts 
to generate anti-idiotypic antibody in animals which respond to antigens with 
that idiotype have succeeded only aider multiple repeated immunization with 
the antigen or by immunization with chemically modified or polymerized anti- 
gens  (1,  34,  35).  No  clear  evidence  therefore has  previously  existed  which 
establishes a  role for anti-idiotypic reactivity in regulation during the normal 
course of an immune response after conventional immunization. 
The exact mechanisms by which anti-idiotypic recognition regulates B-cell 
responsiveness is unknown, but any of several identifiable modes of cell recep- 
tor-anti-receptor interaction may be responsible for the antibody-specific immu- 
noregulation  presented  in  this  report.  It  is  possible,  for  example,  that  the 
homing pattern of transferred idiotype-bearing cells in hapten-carrier immu- 
nized recipients is  altered by anti-idiotypic recognition.  In addition,  anti-idi- 
otypic antibody has been shown capable of blocking B-cell receptor binding to 
antigen thus inducing an acute B-cell suppression (31). Long-term B-cell sup- 
pression specific for receptor allotype or idiotype induced by the administration 
of anti-allotypic or anti-idiotypic antibody has been shown to depend on the 
generation of allotype or idiotype-specific T  cells (29,  32,  36). Understanding 
which of these various mechanisms pertains to the antibody-specific immunore- 
gulation described here may be of great biological interest since this immunore- 
gulation is induced as the result of a  conventional primary humoral immune 
response rather than the passive transfer of antibody. 
A final aspect of the observed phenomenon which warrants discussion is the 
relative  nonsusceptibility  of secondary B  cells  to  this  suppression.  There  is 
evidence to  suggest that  secondary B  cells share receptor idiotypes with the 
primary B-cell repertoire (15,  16). If this is indeed the case, secondary B cells 
should also be recognized by this antibody-specific regulation. However, several SUSAN  K.  PIERCE  AND  NORMAN  R.  KLINMAN  517 
laboratories,  including  this  one,  have  demonstrated  that,  as  a  population, 
secondary B cells are characteristically different from the B cells of nonimmune 
animals, particularly with respect to the ease with which they can be antigeni- 
cally stimulated  (4,  14,  16).  This  may explain the stimulation  of secondary B 
cells in an environment which is nonpermissive for primary B-cell stimulation. 
More importantly,  this difference between primary and secondary B cells may 
have enormous biological relevance in that the existence of secondary B  cells 
may provide the opportunity for the regulation of primary B-cell responses while 
enabling the animal to respond to the same antigen upon restimulation.  In this 
light one could postulate that, if antigen stimulated only the regulatory limb of 
the immune response during  a primary immunization without generating  sec- 
ondary B cells, animals could be rendered functionally tolerant to the antigen. 
These findings have had important practical applications in allowing primary 
B-cell responses to antigens for which carrier molecules are not readily availa- 
ble.  Primary  B-cell responses  in the  fragment  culture  system are  absolutely 
dependent on carrier priming of the recipient mouse (4, 16, 17). In the past it was 
not  possible to  obtain  carrier-specific  help  for  primary  in  vitro  responses  to 
viruses  and  bacteria  by  immunizing  recipients  with  the  particular  virus  or 
bacterium. These experiments not only offer a possible explanation for why this 
was the  case since primary  B  cells specific for the  same determinants  would 
have been suppressed but, more importantly, the difficulty can now be bypassed 
by selecting the appropriate strain combinations for analysis so that donor and 
recipient strains  do not share immunoglobulin  heavy chain genes.  Employing 
this method we have been able to generate primary B-cell responses to a variety 
of complex antigens including varius strains of influenza virus. 
Summary 
In recent years, much evidence has accumulated which demonstrates that an 
animal's  immune  system has  the  capacity to recognize  its  own antibody  idi- 
otypes. These  findings  suggest that  self-idiotypic recognition  may potentially 
play a role in the regulation of B-cell responses. The experiments presented in 
this  report were carried out to determine  if an  animal  develops the ability to 
specifically regulate the synthesis of antibodies specific for an antigen,  subse- 
quent to primary immunization to the particular antigen and concomitant with 
an initial antibody response. Employing the splenic fragment culture system we 
have compared the response of primary  donor B  cells in irradiated  recipients 
which have  been previously immunized  to hemocyanin  (Hy) alone or dinitro- 
phenyl  (DNP)-Hy plus  Hy.  The  results  indicated  that  only 25-30%  of DNP- 
specific  B  cells stimulated  by DNP-Hy in  Hy immunized  recipients  could be 
stimulated by DNP-Hy in recipients immunized with Hy as well as DNP°Hy. B- 
cell  responses  to  other  haptens,  such  as  fluoresceinated-Hy,  and  secondary 
DNP-specific B-cell responses were unaffected in DNP-Hy immunized animals. 
The  nontrivial  and specific nature  of the observed decrease in primary  DNP- 
specific B-cell responses was verified by the finding that the response of CB20 
donor cells, which differ from BALB/c mice only in the immunoglobulin heavy 
chain allotype-linked locus, was unaffected in BALB/c recipient mice which had 
been immunized  with DNP-Hy.  Thus,  it appeared that during  a  primary hu- 
moral immune response to a T-dependent antigen,  an antibody-specific regula- 518  ANTIBODY-SPECIFIC  IMMUNOREGULATION 
tory mechanism is induced which specifically limits the stimulation of hapten- 
specific primary,  but  not  secondary,  B  cells.  The  important  implications  that 
these  findings  have  for  the  understanding  of the  control  of primary  B-cell 
responses and the generation of secondary B  cells is discussed. 
Received for publication  7 March 1977. 
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